1. Medtech Insight

AI Medical Technology Doubles Down On Melanoma With Trials And Financing

 
• By Barnaby Pickering

Over the past month, the company has released positive clinical trial results and raised more cash, both of which will help on its way to combat melanoma.

Is it a mole? Or is it skin cancer? AI Medical Technology's Dermalyser aims to give doctors more confidence when making decisions either way. • Source: Shutterstock

2023 might just be the toughest year yet for medtech startups.

Public markets are down, venture capital is more hesitant than ever after making staggering losses in 2022 and now more than ever, payers are demanding solid clinical evidence before even entertaining new ideas

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D